tiprankstipranks
Evaxion Biotech (EVAX)
NASDAQ:EVAX
US Market
EVAX
Evaxion Biotech
RESEARCH TOOLSreports
Want to see EVAX full AI Analyst Report?

Evaxion Biotech (EVAX) Stock News & Sentiment

403 Followers
Evaxion Unveils New Glioblastoma Vaccine Data Showcasing Scalability of AI-Immunology Platform
Premium
Company Announcements
Evaxion Unveils New Glioblastoma Vaccine Data Showcasing Scalability of AI-Immunology Platform
2d ago
6K
EVAX
Evaxion Posts Strong Phase 2 Data as AI-Designed Cancer Vaccine Hits 86% Target Precision
Premium
Company Announcements
Evaxion Posts Strong Phase 2 Data as AI-Designed Cancer Vaccine Hits 86% Target Precision
2d ago
6K
EVAX
Evaxion Approves 2025 Report and Refreshes Board at April 16 AGM
Premium
Company Announcements
Evaxion Approves 2025 Report and Refreshes Board at April 16 AGM
3d ago
6K
EVAX
Evaxion Completes One-Year Extension of Phase 2 Trial for AI-Designed Melanoma Vaccine EVX-01
Premium
Company Announcements
Evaxion Completes One-Year Extension of Phase 2 Trial for AI-Designed Melanoma Vaccine EVX-01
12d ago
6K
EVAX
Evaxion to Unveil AI-Designed Polio and CMV Vaccine Concepts at World Vaccine Congress
Premium
Company Announcements
Evaxion to Unveil AI-Designed Polio and CMV Vaccine Concepts at World Vaccine Congress
20d ago
6K
EVAX
Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations
Premium
Company Announcements
Evaxion Calls April 16, 2026 AGM to Expand Capital and Warrant Authorizations
1M ago
6K
EVAX
Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting
Premium
Company Announcements
Evaxion Biotech Sets April 16, 2026 Date for Annual General Meeting
1M ago
6K
EVAX
More EVAX News >

EVAX News on the Web

Evaxion Unveils New Glioblastoma Vaccine Data Showcasing Scalability of AI-Immunology Platform
TipRanks News
Bullish
Evaxion Posts Strong Phase 2 Data as AI-Designed Cancer Vaccine Hits 86% Target Precision
TipRanks News
Bullish
Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial
TipRanks News
Bullish
Evaxion Biotech announces new data to be presented at AACR meeting
TipRanks News
Bullish
Evaxion Approves 2025 Report and Refreshes Board at April 16 AGM
TipRanks News
Neutral
Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX)
TipRanks News
Neutral
Evaxion Completes One-Year Extension of Phase 2 Trial for AI-Designed Melanoma Vaccine EVX-01
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
EVAX
Sector Average
Media Buzz
This Week5 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EVAX’s Media Buzz Sentiment?
5 articles about EVAX were published this week. In an average week, 2.25 articles are published.
    What is EVAX’s weekly average amount of articles?
    In an average week, 2.25 articles about EVAX are published.
      What is EVAX’s News Sentiment?
      100% of articles about EVAX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        ALLOAllogene Therapeutics
        TXTMProText Mobility
        HVOOpen Orphan Plc
        RVMDRevolution Medicines
        ALGSAligos Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week